Krill Oil - the Omega 3 with great inflammatory potential

Antarctic Krill Oil is a high quality product, containing Neptune NKO® Krill Oil, which is scientifically proven to be a significant source of unique phospholipids, rich in antioxidants and the two essential Omega-3 polyunsaturated fatty acids, EPA and DHA. NKO® represents a good to excellent source of choline.
Neptune Krill Oil - the only omega-3 source offering:
- First and only clinically proven Omega-3 Marine Phospholipids
- Omega-3 EPA/ DHA functionalized marine phospholipids and potent antioxidants
- Proprietary Composition
- Sourced from Antartic Krill (most abundant biomass)
- Superior bioavailability
- Clinically proven health benefits at recommended daily intake
- Validated safety and long term stability
- No trans fat
- No reflux
- No heavy metals / no dioxins
- No detected allergen
Independent testing reveals the antioxidant power of NKO® to be:
- Over 300 times greater than Vitamins A & E
- Over 48 times greater than Omega-3 Fish Oil
- Over 34 times greater than Co Q-10
Neptune - a Canadian based company - is continuously investing in medical research aimed at demonstrating the benefits of its novel products on human health. The results obtained during clinical research conducted by independent University researchers and healthcare professionals show that Neptune Krill Oil NKO® may provide therapeutic benefits in the following human conditions:
Hyperlipidemia/ Cholesterol Management
NKO® is effective in controlling hyperlipidemia by significantly reducing total cholesterol levels, LDL (bad cholesterol) and triglycerides, while increasing HDL (good cholesterol) to as yet unmatched levels.
NKO® (1 - 1.5 g/day) was shown to be safe and significantly more effective than fish oil in the management of hyperlipidemia. In the same study, NKO® was shown to achieve a significantly greater reduction of LDL levels and increase of HDL levels as compared to fish oil (3g/day). These results were generated among statin-resistant patients, who failed to attain the target LDL levels after at least six months of low dose statin treatment.
Chronic Inflammation and Osteoarthritis
A Phase II clinical study on the effects of NKO® on conditions relating to chronic inflammation and osteoarthritis, published in May 2007 in the peer-reviewed medical journal - Journal of the American College of Nutrition - demonstrated that NKO® within a short treatment period can significantly reduce the C-reactive protein and osteoarthritic symptoms in patients diagnosed with a chronic inflammatory disease.
Many forms of arthritis such as osteoarthritis and rheumatoid arthritis are inflammatory disorders; and patients suffer from pain, stiffness, swelling and functional impairment. Osteoarthritis is the most common form of arthritis affecting over 20 million people in the United States. It and it is caused by the breakdown and eventual loss of the cartilage between the bones of the joints. Non-surgical treatment options for osteoarthritis include analgesic and anti-inflammatory pain medications, nutritional supplementation, physical therapy, exercise, and weight loss.
Premenstrual Syndrome
The results of a double blind clinical study on the effects of NKO® on the management of premenstrual syndrome (PMS) published in May 2003 in a Alternative Medicine Review demonstrate that NKO® can significantly reduce both the physical and emotional symptoms associated with PMS (premenstrual syndrome), and that it is significantly more effective than fish oil (omega-3 18:12) in the management of physical and emotional dysmenorrheal symptoms.
Skin Cancer
Animal studies on skin cancer caused by UV radiation indicate that NKO® can prevent skin damage caused by chronic exposure to UV rays.
Attention Deficit and Hyperactivity Disorder (ADHD)
The clinical results obtained during an open label pilot study demonstrated that NKO® may significantly improve cognitive function (among others concentration, planning skills and focus) of adults suffering from ADHD. The recorded observations were indicative of the neurological advantages of using Neptune Krill Oil over a controlled period of time.
Take 2 to 4 capsules before breakfast, to reach a saturation. After 2 weeks, take 1 to 2 capsules as a maintance dose.
Note: If you take anticoagulants, please consult your physician before taking Krilloil.
2 Capsules (daily dose/1g) contains:
- 400mg Phospholipide-Omega-3 Complex
- 300 mg Total Omega-3 Fatty Acids
- 150 mg EPA (Eicosapentaenoic acid)
- 90 mg DHA (Docosahexaenoic acid)
- 20 mg Total Omega-6 Fatty Acids/li>
- 100 mg Total Omega-9 Fatty Acids
- 1,25 mg Astaxanthine
- 74 mg Choline
- 100 IE/ 30 mcg Vitamin A
- 0,5 IE/0,34 mg Vitamin E
Ingredients:
NKO® Neptune Krill Oil*, Fish Gelatine (capsules), Glycerine, Water
* NKO® is a trademark of Neptune Technologies and Bioressources Inc. Québec, Canada
Allergen Info: Contains protein from crusteans and fish.
Storage Info: Protect product from light and store at room temperature. If desired, you can also store the product in the refrigerator.
Guaranteed pure and free from additives:
- free from lactose, gluten, sugar, salt, eggs, yeast
- free from wheat and dairy products
- free from artificial colors and preservatives
- free from genetically modified substances
- suitable for Diabetics
What is Krill?
Krill is a generic term used to designate all deepwater marine planktonic crustacean species. It looks like miniature shrimp, ranging between one and six centimeters in length. These 85 species represents the planet's most abundant animal biomass found in banks that may extend over several square kilometers. Neptune sources its krill from the Antarctic Ocean.
The management and control of krill harvesting is led by the 25-state member Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR), which is the official and reliable international organization responsible for krill fishery management.
Many studies have been undertaken and they show that the biomass of Antarctic krill, one of the world's most abundant biomass, may amount to 500 million tons. This standing stock is subject to annual natural reproduction providing renewable krill for predation, natural mortality and human exploitation.
The precautionary catch limit set by the CCAMLR was 6.6 million tons for 2008 and is reviewed annually. It was increased from 4.9 million tons in 2005/06 based on the results of recent surveys.
Less than 2% of the precautionary catch limit is actually harvested, which means that the catch limit is unlikely to be reached in the foreseeable future. The precautionary catch limits on the krill fishery are under constant review by the Scientific Committee of CCAMLR which uses an ecosystem approach to management.
The annual natural reproduction of Antarctic krill is at least several hundred million tons constantly renewing the standing stock and granting sufficient krill for all marine mammals and fish, birds and human exploitation.
Antarctic baleen whales are estimated to consume 85 million tons per year. Less than 120,000 tons of the annually set total catch limit of 6.6 million tons are harvested by fisheries.
Since Neptune's activities rely on krill as a biomass to benefit human health, its conservation is in its foremost interest which leads the Company to continuously monitor the ecological- and environmental-friendly harvest of its krill.
Please enter a quantity before clicking "Add to Shopping Cart".
Please reduce the quantity to the available units.